{"id":36133,"date":"2025-10-27T14:22:36","date_gmt":"2025-10-27T13:22:36","guid":{"rendered":"https:\/\/mabdesign.fr\/andzonbio1-nouveau-membre\/"},"modified":"2025-10-27T14:25:10","modified_gmt":"2025-10-27T13:25:10","slug":"andzonbio1-nouveau-membre","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/","title":{"rendered":"AndzonBio1 – new member"},"content":{"rendered":"\n

First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.
Thanks to a proven and rigorous selection process, we are strategically positioned to develop the best projects from Europe\u2019s top academic research centers such as Inserm in France.
Our aim is to derisk up to 4 breakthrough therapeutic programs bringing them closer to the clinic and transition into a leading CVRM Biotech company. To know more<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.<\/p>\n","protected":false},"author":3,"featured_media":35846,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33,36],"tags":[],"class_list":["post-36133","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-new-member","category-news"],"yoast_head":"\nAndzonBio1 - new member - MabDesign<\/title>\n<meta name=\"description\" content=\"First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases. First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AndzonBio1 - new member - MabDesign\" \/>\n<meta property=\"og:description\" content=\"First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases. First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-27T13:22:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-27T13:25:10+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1265\" \/>\n\t<meta property=\"og:image:height\" content=\"312\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Laure Delhon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laure Delhon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/\"},\"author\":{\"name\":\"Laure Delhon\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\"},\"headline\":\"AndzonBio1 – new member\",\"datePublished\":\"2025-10-27T13:22:36+00:00\",\"dateModified\":\"2025-10-27T13:25:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/\"},\"wordCount\":87,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg\",\"articleSection\":[\"New member\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/\",\"name\":\"AndzonBio1 - new member - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg\",\"datePublished\":\"2025-10-27T13:22:36+00:00\",\"dateModified\":\"2025-10-27T13:25:10+00:00\",\"description\":\"First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases. First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg\",\"width\":1265,\"height\":312},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AndzonBio1 – new member\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\",\"name\":\"Laure Delhon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"caption\":\"Laure Delhon\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AndzonBio1 - new member - MabDesign","description":"First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases. First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/","og_locale":"en_US","og_type":"article","og_title":"AndzonBio1 - new member - MabDesign","og_description":"First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases. First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.","og_url":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/","og_site_name":"MabDesign","article_published_time":"2025-10-27T13:22:36+00:00","article_modified_time":"2025-10-27T13:25:10+00:00","og_image":[{"width":1265,"height":312,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg","type":"image\/jpeg"}],"author":"Laure Delhon","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Laure Delhon","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/"},"author":{"name":"Laure Delhon","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39"},"headline":"AndzonBio1 – new member","datePublished":"2025-10-27T13:22:36+00:00","dateModified":"2025-10-27T13:25:10+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/"},"wordCount":87,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg","articleSection":["New member","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/","url":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/","name":"AndzonBio1 - new member - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg","datePublished":"2025-10-27T13:22:36+00:00","dateModified":"2025-10-27T13:25:10+00:00","description":"First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases. First company to emerge from the AndzonBio Model of pipeline builders powered by AdBio Partners and Inserm Transfert, AndzonBio1 focuses on CardioVascular Renal and Metabolic (CVRM) diseases.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/jet-form-builder\/12658bb1c077cf59543527b032306a8a\/2025\/09\/OCoOCo\u252caANDZONBIO-1_COULEUR-QUADRI.jpg","width":1265,"height":312},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/andzonbio1-nouveau-membre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"AndzonBio1 – new member"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39","name":"Laure Delhon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","caption":"Laure Delhon"},"url":"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/36133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=36133"}],"version-history":[{"count":1,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/36133\/revisions"}],"predecessor-version":[{"id":36134,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/36133\/revisions\/36134"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/35846"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=36133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=36133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=36133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}